Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance

Pfizer (PFE) Tops Q4 EPS by 28c, Tops on Revenue; Offers Guidance

January 30, 2024 6:46 AM EST

Pfizer (NYSE: PFE) reported Q4 EPS of $0.10, $0.28 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $14.25 billion versus the consensus estimate of $14.22 billion.

The company reaffirms Full-Year 2024 guidance provided on December 13, 2023, of Revenues of $58.5 to $61.5 Billion and Adjusted... More